Evidence-Based Thromboprophylaxis for Delayed Hip Fracture Surgery
For patients with post-traumatic hip fractures (intertrochanteric or femoral neck) awaiting surgery delayed 2–4 days, start prophylactic-dose LMWH (e.g., enoxaparin 40 mg daily or dalteparin 5000 IU daily) on admission or as soon as possible after injury, give the last dose on the morning of the day before surgery (approximately 24 hours pre-operatively at half the daily dose if using twice-daily regimens), restart prophylactic-dose LMWH 12 hours after low-bleed-risk procedures or 24 hours after higher-bleed-risk procedures (with therapeutic-dose delayed 48–72 hours if bridging was used), and continue for a minimum of 28–35 days post-operatively.
When to Start Anticoagulation
Start prophylactic LMWH on admission or as soon as possible after the fracture occurs, even before surgery. Hip fracture surgery guidelines explicitly recommend starting thromboprophylaxis "before or as soon as possible after surgery" for hip fracture patients 1. More importantly, a large Norwegian registry study of 20,241 hemiarthroplasties for femoral neck fractures demonstrated that preoperative start of LMWH significantly reduced mortality (RR 0.88, p<0.001) and reoperation rates (RR 0.84, p=0.04) compared to postoperative start, with no increase in bleeding complications or hematoma-related reoperations 2. This finding is critical: delaying thromboprophylaxis until after surgery increases the risk of death.
Dosing on Admission
- Enoxaparin 40 mg subcutaneous once daily 3
- Dalteparin 5000 IU subcutaneous once daily 3
- Fondaparinux 2.5 mg subcutaneous once daily (alternative) 3
These are prophylactic doses, not therapeutic doses. The evidence supports standard prophylactic dosing rather than higher-intensity regimens for pre-operative thromboprophylaxis 4.
Timing of Last Pre-Operative Dose
Give the last dose of LMWH on the morning of the day before surgery (approximately 24 hours before the procedure). If using a twice-daily regimen (e.g., enoxaparin 30 mg BID for orthopedic surgery), give half the total daily dose at this time 5.
The 2022 American College of Chest Physicians guideline specifically recommends administering the last pre-operative LMWH bridging dose approximately 24 hours before surgery rather than 10–12 hours before 5. This timing allows adequate clearance while maintaining thromboprophylaxis coverage. Studies show that when LMWH is given 12 hours pre-operatively, >90% of patients have detectable anticoagulant effect at surgery, with 34% having therapeutic levels—potentially increasing bleeding risk 5.
Practical Algorithm for Last Dose
- Surgery scheduled for 8 AM Wednesday: Give last LMWH dose on Tuesday morning (approximately 24 hours before)
- If using twice-daily dosing: Give half the usual dose (e.g., enoxaparin 30 mg instead of 60 mg total daily)
- If using once-daily dosing: Give the full prophylactic dose (e.g., enoxaparin 40 mg)
When to Restart Post-Operatively
Restart prophylactic-dose LMWH 12 hours after surgery for most hip fracture procedures, or 24 hours after surgery if there are specific bleeding concerns. The timing depends on surgical hemostasis and bleeding risk 5.
Post-Operative Restart Algorithm
For standard hip fracture surgery (hemiarthroplasty, ORIF):
- 12 hours post-operatively: Restart prophylactic-dose LMWH (enoxaparin 40 mg daily or dalteparin 5000 IU daily) if hemostasis is adequate 3
- This is considered a low-to-moderate bleed-risk procedure in most cases
For procedures with higher bleeding concern or inadequate hemostasis:
- 24–48 hours post-operatively: Delay restart until hemostasis is confirmed 5
- Consider mechanical prophylaxis (intermittent pneumatic compression) in the interim 3
If the patient was on therapeutic anticoagulation pre-injury (e.g., for atrial fibrillation) and required bridging:
- 48–72 hours post-operatively: Resume therapeutic-dose LMWH only after adequate hemostasis 3, 5
- Use prophylactic-dose LMWH in the first 24–48 hours as a bridge 5
Critical Caveat: Neuraxial Anesthesia
If spinal or epidural anesthesia was used, wait at least 12 hours after catheter removal before giving LMWH to reduce the risk of epidural hematoma 6. For patients receiving prophylactic-dose LMWH once daily, neuraxial catheter removal should occur at least 12 hours after the last dose, and the next dose should be delayed at least 4 hours after catheter removal 6.
Duration of Prophylaxis
Continue LMWH for a minimum of 28–35 days after hip fracture surgery. This extended duration is strongly recommended for hip fracture patients 1, 3, 4, 7.
Duration Guidelines
- Minimum duration: 10–14 days for all major orthopedic surgery 3, 4
- Recommended duration for hip fracture: 28–35 days (up to 5 weeks) 1, 3, 4, 7
- Rationale: Hip fracture patients remain at elevated VTE risk well beyond hospital discharge due to continued immobility, advanced age, comorbidities, and trauma 4, 7
The 2012 ACCP guidelines (9th edition) specifically state: "For hip arthroplasty and hip fracture surgery, we recommend continuing thromboprophylaxis for a minimum of 10 days and up to 35 days" (Grade 1A recommendation) 4. The 2008 ACCP guidelines similarly recommend extending prophylaxis beyond 10 days and up to 35 days for hip fracture surgery 7.
Practical Implementation
- At discharge: Prescribe LMWH to complete 28–35 days total from surgery
- Patient/family education: Teach subcutaneous injection technique or arrange home health nursing
- Alternative if LMWH not feasible: Warfarin (INR 2.0–3.0) can be used, though LMWH is preferred 1, 3
- Rivaroxaban: 10 mg daily for 10–35 days is an alternative for orthopedic surgery, though less studied specifically for hip fracture 3
Special Considerations and Common Pitfalls
Renal Impairment
- CrCl 30–50 mL/min: Reduce fondaparinux to 1.5 mg daily 3; consider dose adjustment for LMWH
- CrCl <30 mL/min: Avoid fondaparinux; consider unfractionated heparin or reduced-dose LMWH with anti-Xa monitoring 8
Bleeding Risk vs. Thrombotic Risk
The Norwegian registry data definitively shows that preoperative LMWH does not increase bleeding complications compared to postoperative start 2. The mortality benefit of early thromboprophylaxis outweighs theoretical bleeding concerns in hip fracture patients.
Mechanical Prophylaxis
- Add intermittent pneumatic compression (IPC) if pharmacologic prophylaxis is contraindicated due to active bleeding 3
- Do not use mechanical methods alone unless pharmacologic prophylaxis is absolutely contraindicated 9, 3
Delay to Surgery
Patients with hip fracture face progressive mortality and morbidity with delays beyond 24–48 hours 10. Do not delay surgery solely to allow LMWH washout if the patient has been receiving prophylactic doses. The 24-hour pre-operative interval is sufficient for prophylactic-dose LMWH clearance 5.
Antiplatelet Medications
If the patient is taking clopidogrel or other antiplatelet agents, do not delay trauma surgery 11. LMWH should still be given for VTE prophylaxis, as antiplatelet agents do not prevent venous thromboembolism 11.
Summary Algorithm
- On admission: Start enoxaparin 40 mg SC daily (or dalteparin 5000 IU SC daily)
- Last pre-op dose: Morning of the day before surgery (~24 hours before)
- Post-operative restart: 12 hours after surgery (or 24 hours if bleeding concerns)
- Duration: Continue for 28–35 days total from surgery
- Monitor: Ensure adequate hemostasis before each dose; adjust for renal function
This approach is supported by the highest-quality evidence showing reduced mortality with preoperative thromboprophylaxis 2 and strong guideline recommendations for extended-duration prophylaxis in hip fracture patients 1, 3, 1, 4, 7.